North America Iodinated Contrast Media in Interventional X-Ray Market - Industry Trends and Forecast To 2027

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF NORTH AMERICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 MULTIVARIATE MODELLING

2.7 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.8 APPLICATION GRID

2.9 DBMR MARKET POSITION GRID

2.10 VENDOR SHARE ANALYSIS

2.11 SECONDARY SOURCES

2.12 ASSUMPTION

3 MARKET OVERVIEW

3.1 DRIVERS

3.1.1 LARGE NUMBER OF APPROVALS FOR IODINATED AGENTS

3.1.2 RISING AGING POPULATION

3.1.3 INCREASING NUMBER OF CHRONIC DISEASES

3.1.4 INCREASING RESEARCH ACTIVITIES FOR CONTRAST AGENTS

3.2 RESTRAINTS

3.2.1 HIGH COST OF CONTRAST MEDIA

3.2.2 SIDE EFFECTS ASSOCIATED WITH CONTRAST AGENTS

3.3 OPPORTUNITIES

3.3.1 GROWING HEALTHCARE INFRASTRUCTURE

3.3.2 STRATEGIC INITIATIVE BY MARKET PLAYERS

3.3.3 GROWING NUMBER OF DIAGNOSTIC CENTERS

3.3.4 UPCOMING GENERIC CONTRAST MEDIA AGENTS

3.4 CHALLENGES

3.4.1 LACK OF AWARENESS REGARDING THE PROPER DOSAGE OF CONTRAST AGENT

3.4.2 RESTRICTION AND WITHDRAWAL OF LINEAR GADOLINIUM-BASED CONTRAST AGENTS

4 EXECUTIVE SUMMARY

5 PREMIUM INSIGHTS

6 NORTH AMERICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION

6.1 OVERVIEW

6.2 INTRAVENOUS

6.3 ORAL

6.4 RECTAL

6.5 OTHERS

7 NORTH AMERICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER

7.1 OVERVIEW

7.2 HOSPITAL

7.3 SPECIALTY CLINICS

7.3.1 IMAGING CENTERS

7.3.2 PRIVATE PRACTICES

7.4 DIAGNOSTIC CENTERS

7.5 AMBULATORY SURGICAL CENTERS

7.6 RESEARCH & ACADEMIC INSTITUTES

8 NORTH AMERICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION

8.1 OVERVIEW

8.2 CARDIOLOGY

8.2.1 PERCUTANEOUS CORONARY DISEASE

8.2.2 STRUCTURAL HEART DISEASE

8.2.3 CONGENITAL HEART DISEASE

8.2.4 ELECTROPHYSIOLOGY

8.3 NEUROLOGY

8.4 GENERAL SURGERY

8.5 ONCOLOGY

8.6 UROLOGY

9 NORTH AMERICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE

9.1 OVERVIEW

9.2 NON-IONIC

9.3 IONIC

10 NORTH AMERICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY GEOGRAPHY

10.1 NORTH AMERICA

10.1.1 U.S.

10.1.2 CANADA

10.1.3 MEXICO

11 NORTH AMERICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, COMPANY LANDSCAPE

11.1 COMPANY SHARE ANALYSIS: NORTH AMERICA

12 COMPANY PROFILES

12.1 BRACCO DIAGNOSTIC INC.

12.1.1 COMPANY SNAPSHOT

12.1.2 COMPANY SHARE ANALYSIS

12.1.3 PRODUCT PORTFOLIO

12.1.4 RECENT DEVELOPMENT

12.2 GENERAL ELECTRIC

12.2.1 COMPANY SNAPSHOT

12.2.2 REVENUE ANALYSIS

12.2.3 COMPANY SHARE ANALYSIS

12.2.4 PRODUCT PORTFOLIO

12.2.5 RECENT DEVELOPMENTS

12.3 GUERBET

12.3.1 COMPANY SNAPSHOT

12.3.2 REVENUE ANALYSIS

12.3.3 COMPANY SHARE ANALYSIS

12.3.4 PRODUCT PORTFOLIO

12.3.5 RECENT DEVELOPMENT

12.4 BAYER AG

12.4.1 COMPANY SNAPSHOT

12.4.2 REVENUE ANALYSIS

12.4.3 PRODUCT PORTFOLIO

12.4.4 RECENT DEVELOPMENT

12.5 IMAX

12.5.1 COMPANY SNAPSHOT

12.5.2 PRODUCT PORTFOLIO

12.5.3 RECENT DEVELOPMENT

12.6 ISO-TEX DIAGNOSTICS, INC.

12.6.1 COMPANY SNAPSHOT

12.6.2 PRODUCT PORTFOLIO

12.6.3 RECENT DEVELOPMENT

12.7 J.B.CHEMICALS AND PHARMACEUTICALS LTD.

12.7.1 COMPANY SNAPSHOT

12.7.2 REVENUE ANALYSIS

12.7.3 PRODUCT PORTFOLIO

12.7.4 RECENT DEVELOPMENT

12.8 NOVALEK PHARMACEUTICALS PVT. LTD.

12.8.1 COMPANY SNAPSHOT

12.8.2 PRODUCT PORTFOLIO

12.8.3 RECENT DEVELOPMENT

12.9 TAEJOON PHARM

12.9.1 COMPANY SNAPSHOT

12.9.2 PRODUCT PORTFOLIO

12.9.3 RECENT DEVELOPMENT

12.10 UNIJULES LIFE SCIENCES LTD.

12.10.1 COMPANY SNAPSHOT

12.10.2 PRODUCT PORTFOLIO

12.10.3 RECENT DEVELOPMENT

13 QUESTIONNAIRE

14 RELATED REPORTS

UU

TABLE 1 LIST OF FDA APPROVED NON-IONIC IODINATED AGENTS

TABLE 2 LIST OF FDA APPROVED IONIC IODINATED AGENTS

TABLE 3 COST OF CONTRAST MEDIA

TABLE 4 LIST OF UPCOMING GENERIC CONTRAST MEDIA AGENTS

TABLE 5 DOSAGE OF CONTRAS MEDIA TO BE TAKEN AS PER PATIENT’S WEIGHT

TABLE 6 NORTH AMERICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)

TABLE 7 NORTH AMERICA INTRAVENOUS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 8 NORTH AMERICA ORAL IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 9 NORTH AMERICA RECTAL IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 10 NORTH AMERICA OTHERS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 11 NORTH AMERICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 12 NORTH AMERICA HOSPITAL IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 13 NORTH AMERICA SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 14 NORTH AMERICA SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 15 NORTH AMERICA DIAGNOSTIC CENTERS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 16 NORTH AMERICA AMBULATORY SURGICAL CENTERS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 17 NORTH AMERICA RESEARCH & ACADEMIC INSTITUTES IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 18 NORTH AMERICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 19 NORTH AMERICA CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 20 NORTH AMERICA CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 21 NORTH AMERICA NEUROLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 22 NORTH AMERICA GENERAL SURGERY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 23 NORTH AMERICA ONCOLOGY SURGERY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 24 NORTH AMERICA UROLOGY SURGERY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 25 NORTH AMERICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)

TABLE 26 NORTH AMERICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITER)

TABLE 27 NORTH AMERICA NON-IONIC IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 28 NORTH AMERICA IONIC IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 29 NORTH AMERICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY COUNTRY, 2018-2027 (USD MILLION)

TABLE 30 NORTH AMERICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)

TABLE 31 NORTH AMERICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 32 NORTH AMERICA CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 33 NORTH AMERICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)

TABLE 34 NORTH AMERICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 35 NORTH AMERICA SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 36 NORTH AMERICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)

TABLE 37 U.S. IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)

TABLE 38 U.S. IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 39 U.S. CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 40 U.S. IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)

TABLE 41 U.S. IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 42 U.S. SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 43 U.S. IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)

TABLE 44 U.S. IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (PRICE PER LITRE (USD))

TABLE 45 CANADA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)

TABLE 46 CANADA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 47 CANADA CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 48 CANADA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)

TABLE 49 CANADA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 50 CANADA SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 51 CANADA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)

TABLE 52 CANADA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (PRICE PER LITRE (USD))

TABLE 53 MEXICO IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)

TABLE 54 MEXICO IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 55 MEXICO CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 56 MEXICO IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)

TABLE 57 MEXICO IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 58 MEXICO SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 59 MEXICO IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)

TABLE 60 MEXICO IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (PRICE PER LITRE (USD))